Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
Published
02/25/2021 at 5:15 am
Downloads
1
Related Resources
Scientific Review of FDA's Draft Risk Profile on Spices
Positions & Comments
Allergens & Other Food Safety Issues
2/28/2014
This document is a letter from February 2014 from James S Dickson to ASTA containing a scientific review of the FDA's Draft Risk Profile on Spices.
ASTA Comments to FDA on Sesame Allergens
Positions & Comments
Allergens & Other Food Safety Issues
12/31/2018
ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.
